Although the pathogenic role of CD8+ T-cells in MS remains largely speculative, the studies discussed above strongly suggest that there is now ample evidence for the regulatory role for CD8+ T-cell subsets in the disease process. Here, CD8A is linked to myeloid sarcoma.